Bayer Lunch Symposium: Personalized Treatment of Hepatocellular Carcinoma: Seeking Solutions Through Multidisciplinary Collaboration
Bayer Lunch Symposium
Exploring the infrastructure for personalised management of hepatocellular carcinoma (HCC)
Josep M. Llovet, MD (Spain/USA)
Locoregional therapy of HCC: opportunities and limitations
Riccardo Lencioni, MD (Italy)
Systemic targeted therapy in HCC: Are we making progress?
Andrew Zhu, PhD (USA)